Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Sexual Transmitted DiseaseVaginosis, BacterialMycosisUrogenital DiseaseHPVDysbiosisToxic Shock SyndromeMenstrual Cup
Interventions
OTHER

Samples collection (whole blood, urine, vaginal and cervical cells)

During the clinical visit, samples will be collected from participants, including blood, urine, and vaginal and cervical cells. These samples will be used for a range of analyses, including determination of the vaginal microbiota composition and sequencing, cytokine profiling, and assessment of local immunity through flow cytometry using CyTOF technology. Urine samples will be analyzed for pollutants such as phthalates and bisphenol, while blood samples will be used for blood cell counts.

Trial Locations (1)

75014

Institut Alfred Fournier, Paris

All Listed Sponsors
collaborator

Institut Alfred Fournier

UNKNOWN

lead

Centre National de la Recherche Scientifique, France

OTHER

NCT07199998 - Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota | Biotech Hunter | Biotech Hunter